Evidence map

ReviewCurrent hypertension reports2017

Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?

Hamish Cg Prosser et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2017
2018
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 28349377